Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
5,025.00    80.00 (1.63%)
Bid:
5,000.00
Ask:
5,050.00
Spread: 50.00 (1.00%)
Market Cap: £333.03m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Director/PDMR Shareholding

30 Jul 2025 07:00

RNS Number : 0866T
Judges Scientific PLC
30 July 2025
 

Judges Scientific plc

Director/PDMR Shareholding

Judges Scientific plc (AIM: JDG), a group focused on acquiring and developing companies in the scientific instrument sector announces that David Cicurel, Chief Executive Officer, and his spouse on 29 July 2025 effected a "Bed and ISA" by way of:

1. the sale of 310 ordinary shares of 5p each in the Company ("Ordinary Shares") by David Cicurel and immediate repurchase of the same number of Ordinary Shares, each at a price of 6425 pence per share, into David's ISA, and;

 

2. the sale of 315 Ordinary Shares by David Cicurel's spouse at a price of 6400 pence per share and immediate repurchase of the same number of Ordinary Shares at a price of 6410 pence per share, into her ISA.

Following this transaction David Cicurel's total beneficial and non-beneficial interest in Ordinary Shares remains unchanged. He is beneficially interested in 544,369 Ordinary Shares and beneficially and non beneficially interested in 611,369 Ordinary Shares, his non beneficial interest comprising 67,000 Ordinary Shares he has gifted to Shoftim Charitable Trust.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

David Cicurel

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Judges Scientific plc

b)

 

LEI

 

 

2138004EXWWPTW1JOL31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares in Judges Scientific plc

 

 

GB0032398678

 

b)

 

Nature of the transaction

 

 

Sale and repurchase of Ordinary Shares through a "Bed and ISA" arrangement

c)

 

Price(s) and volume(s)

 

 

 

Type

Price(s)

 

Volume(s)

Sale

6425p

 

310

 

Purchase

6425p

 

310

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

Type

Price(s)

 

Volume(s)

Sale & repurchase

6425p

 

310

 

 

 

e)

 

Date of the transaction

 

 

29/07/25

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Alejandra Cicurel

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Person Closely Associated with David Cicurel, Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Judges Scientific plc

b)

 

LEI

 

 

2138004EXWWPTW1JOL31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares in Judges Scientific plc

 

 

GB0032398678

 

b)

 

Nature of the transaction

 

 

Sale and repurchase of Ordinary Shares through a "Bed and ISA" arrangement

c)

 

Price(s) and volume(s)

 

 

 

Type

Price(s)

 

Volume(s)

Sale

6400p

 

315

 

Purchase

6410p

 

315

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

Type

Price(s)

 

Volume(s)

Sale

6400p

 

315

 

Purchase

6410p

 

315

 

 

 

e)

 

Date of the transaction

 

 

29/07/25

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

- Ends -  

 For further information please contact:

 

 

 

Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, CFO

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Joint Broker)

Stephane Auton

Harry Davies-Ball

Tel: +44 (0) 20 7408 4090

 

Liberum (Joint Broker)

Edward Mansfield

Nikhil Varghese

Josh Borlant

Tel : +44 (0) 20 3100 2222

 

 

Investec Bank plc (Joint Broker)

Virginia Bull

Carlton Nelson

Tel: +44 (0) 207 597 4000

Alma PR (Financial Public Relations)

Sam Modlin

Joe Pederzolli

Rebecca Sanders-Hewett

Sarah Peters

Tel: +44 (0) 20 3405 0205

judges@almapr.co.uk

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 25 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.

For further information, please visit www.judges.uk.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDBGDRDXDDGUC
Date   Source Headline
19th Sep 20177:00 amRNSInterim Results for the 6M ended 30 June 2017
6th Sep 201711:10 amRNSDirector/PDMR Shareholding
6th Sep 201711:10 amRNSDirector/PDMR Shareholding
6th Sep 201711:08 amRNSDirector/PDMR Shareholding
8th Aug 20175:12 pmRNSDirector/PDMR Shareholding
8th Aug 20175:12 pmRNSDirector/PDMR Shareholding
8th Aug 20175:11 pmRNSDirector/PDMR Shareholding
1st Aug 20177:00 amRNSTotal Voting Rights
27th Jul 20177:00 amRNSNotice of Results
21st Jul 20179:51 amRNSDirector/PDMR Shareholding
21st Jul 20179:20 amRNSHolding(s) in Company
20th Jul 20171:57 pmRNSDirector/PDMR Shareholding
20th Jul 20177:00 amRNSTrading Update and Notice of Interim Results
18th Jul 20177:00 amRNSAcquisition
6th Jul 20174:15 pmRNSDirector/PDMR Shareholding
6th Jul 20174:12 pmRNSDirector/PDMR Shareholding
6th Jul 20174:11 pmRNSDirector/PDMR Shareholding
7th Jun 20172:49 pmRNSDirector/PDMR Shareholding
7th Jun 20172:48 pmRNSDirector/PDMR Shareholding
7th Jun 20172:46 pmRNSDirector/PDMR Shareholding
5th Jun 201711:31 amRNSHolding(s) in Company
24th May 201712:52 pmRNSResult of Annual General Meeting
15th May 20177:00 amRNSBlocklisting Return
10th May 20173:39 pmRNSDirector/PDMR Shareholding
10th May 20173:38 pmRNSDirector/PDMR Shareholding
10th May 20173:36 pmRNSDirector/PDMR Shareholding
10th May 20173:35 pmRNSDirector/PDMR Shareholding
2nd May 20177:00 amRNSTotal Voting Rights
28th Apr 20175:10 pmRNSDirector/PDMR Shareholding
7th Apr 20178:57 amRNSDirector/PDMR Shareholding
7th Apr 20178:55 amRNSDirector/PDMR Shareholding
7th Apr 20178:54 amRNSDirector/PDMR Shareholding
3rd Apr 20177:00 amRNSTotal Voting Rights
21st Mar 20177:00 amRNSFinal Results
8th Mar 20172:41 pmRNSDirector/PDMR Shareholding
8th Mar 20172:40 pmRNSDirector/PDMR Shareholding
8th Mar 20172:39 pmRNSDirector/PDMR Shareholding
1st Mar 20177:00 amRNSTotal Voting Rights
8th Feb 20173:50 pmRNSDirector/PDMR Shareholding
8th Feb 20173:45 pmRNSDirector/PDMR Shareholding
8th Feb 20173:40 pmRNSDirector/PDMR Shareholding
1st Feb 20177:00 amRNSTotal Voting Rights
23rd Jan 20177:00 amRNSTrading statement and Notice of Final Results
10th Jan 201712:10 pmRNSDirector/PDMR Shareholding
10th Jan 201712:05 pmRNSDirector/PDMR Shareholding
10th Jan 201712:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20177:00 amRNSTotal Voting Rights
15th Dec 201611:52 amRNSDirector/PDMR Shareholding
13th Dec 20164:15 pmRNSDirector/PDMR Shareholding
13th Dec 20164:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.